Objective: We aimed to compare the ASCVD cardiovascular risk assessment scores released from 2013 ACC/AHA guideline and traditional Framingham 10-year cardiovascular risk score in patients with newly diagnosis with type 2 diabetes. And we also examined their associations with albuminuria. Methods: We investrigated 290 patients from 40 years to 79 years who newly diagnosed with type 2 diabetes at the Pusan National University Yangsan Hospital. The ASCVD cardiovascular risk scores were calculated and the patients were divided as high risk groups (ASCVD risk score ≥ 7.5%) and low risk groups (ASCVD risk score < 7.5%). Framingham risk scores were also calculated and the scores were classified as high risk (≥ 10%) and low risk (< 10%). Results: In a total of 290 patients, 95 (32.8%) patients had a low ASCVD risk score and 195 (67.2%) had a high ASCVD risk score. The risk of developing CVD was more in males than females. The prevalence of albuminuria was more in the high risk group. In low risk group, 46 (48.4%) patients were reclassified as higher risk group according to Framingham risk score. But in high risk group, only 4 (2%) patients were reclassified as lower risk group according to Framingham risk score. The risk factors for albuminuria were different between the low CVD risk groups and high-CVD risk group in adjusted multivariate regression model. In low risk group, lower total bilirubin (OR 0.104) and higher Framingham 10-year risk score (OR 1.160) were significantly related albuminuria. In high risk group, higher SBP (OR 1.025) and higher ASCVD score (OR 1.022) showed significantly positive relation with albuminuria. Conclusion: Two different cardiovascular risk assessment scores did not completely predict occurrence of albuminuria in patients with newly diagnosis with type 2 diabetes. Framingham risk score in low risk group and ASCVD risk score in high risk group showed positive relation with albuminuria.